Research | A.D.A.M. Innovations

top of page

Services
Our science
About
CSR
Careers
News
Events
More

Use tab to navigate through the menu items.

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

A.D.A.M. Innovations Enables Pharmacogenomics for NTT Precision Medicine

Apr 30

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Oxford Nanopore and A.D.A.M. Innovations Announce International Collaboration to Accelerate Advanced Genomic Medicine in Japan

Mar 17

Kansai Medical University and Genesis Healthcare Announce Collaborative Research Harnessing Genomic Big Data and A.I.

Kansai Medical University and Genesis Healthcare Announce Collaborative Research Harnessing Genomic Big Data and A.I.

Kansai Medical University and Genesis Healthcare Announce Collaborative Research Harnessing Genomic Big Data and A.I.

Oct 9, 2024

Covid PCR testing

Related sites

Phone number

+81-(0)3-5422-8506 (Japan)

Location

Yebisu Garden Place Tower 26F, 4-20-3 Ebisu, Shibuya-ku,
Tokyo, 150-6026,
JAPAN

Compliance rules

© 2026 A.D.A.M. Innovations Co. (Japanese corporate name Genesis Healthcare Co.). All rights reserved.

GeneLife, GeneLife WGS, GenesisGaia and GeneLink are registered or pending registration trademarks of A.D.A.M. Innovations Co. (Japanese corporate name Genesis Healthcare Co.)

bottom of page